Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,500 | 446 | 100.0% |
| Education | $3.85 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,559 | 71 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $989.47 | 43 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $873.21 | 37 | $0 (2023) |
| Amgen Inc. | $781.91 | 34 | $0 (2023) |
| PFIZER INC. | $687.65 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $560.78 | 26 | $0 (2020) |
| Biohaven Pharmaceuticals, Inc. | $556.05 | 15 | $0 (2021) |
| GlaxoSmithKline, LLC. | $462.05 | 25 | $0 (2024) |
| Genentech USA, Inc. | $257.13 | 16 | $0 (2022) |
| Allergan, Inc. | $247.26 | 15 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,431 | 54 | AstraZeneca Pharmaceuticals LP ($457.55) |
| 2023 | $931.14 | 43 | NESTLE HEALTHCARE NUTRITION INC. ($273.40) |
| 2022 | $1,317 | 58 | Nestle HealthCare Nutrition Inc. ($287.09) |
| 2021 | $1,621 | 69 | Biohaven Pharmaceuticals, Inc. ($470.40) |
| 2020 | $1,204 | 63 | Amgen Inc. ($181.19) |
| 2019 | $996.07 | 45 | AbbVie, Inc. ($347.53) |
| 2018 | $1,091 | 60 | AbbVie, Inc. ($217.72) |
| 2017 | $912.72 | 55 | Boehringer Ingelheim Pharmaceuticals, Inc. ($207.45) |
All Payment Transactions
447 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $13.50 | General |
| Category: Elastography | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $12.85 | General |
| Category: Elastography | ||||||
| 10/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: DERMATOLOGY | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: PAIN | ||||||
| 09/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/16/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: ANTIBIOTIC | ||||||
| 09/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/03/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: ANTIBIOTIC | ||||||
| 07/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $4.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,133 | 1,915 | $326,950 | $150,425 |
| 2022 | 15 | 1,053 | 1,919 | $345,240 | $163,850 |
| 2021 | 16 | 1,063 | 1,962 | $356,626 | $176,282 |
| 2020 | 12 | 771 | 1,899 | $335,999 | $141,469 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 300 | 859 | $172,250 | $79,879 | 46.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 239 | 239 | $59,750 | $26,879 | 45.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 73 | 141 | $28,200 | $13,998 | 49.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 84 | 147 | $22,030 | $10,117 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 97 | $12,610 | $6,062 | 48.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 40 | 40 | $7,935 | $5,130 | 64.6% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 34 | 35 | $7,000 | $3,289 | 47.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 15 | 16 | $2,880 | $1,386 | 48.1% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 11 | 11 | $1,925 | $900.40 | 46.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 24 | 48 | $2,880 | $778.56 | 27.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 46 | 46 | $3,910 | $481.82 | 12.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 87 | 119 | $2,975 | $405.79 | 13.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 23 | 23 | $575.00 | $372.60 | 64.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 27 | $1,080 | $310.77 | 28.8% |
| 90471 | Administration of vaccine | Office | 2023 | 14 | 14 | $420.00 | $231.14 | 55.0% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 51 | 53 | $530.00 | $204.05 | 38.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 292 | 899 | $180,050 | $85,125 | 47.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 260 | 260 | $65,000 | $31,726 | 48.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 110 | 218 | $32,620 | $15,811 | 48.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 95 | 162 | $32,400 | $15,731 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 66 | $8,670 | $4,115 | 47.5% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2022 | 38 | 41 | $8,200 | $4,038 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 17 | 17 | $3,445 | $2,296 | 66.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 21 | 23 | $4,140 | $2,116 | 51.1% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 12 | 13 | $2,275 | $1,016 | 44.7% |
About Dr. Constantine Vafidis, MD
Dr. Constantine Vafidis, MD is a Family Medicine healthcare provider based in Johnston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2009. The National Provider Identifier (NPI) number assigned to this provider is 1467683227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Constantine Vafidis, MD has received a total of $9,504 in payments from pharmaceutical and medical device companies, with $1,431 received in 2024. These payments were reported across 447 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($9,500).
As a Medicare-enrolled provider, Vafidis has provided services to 4,020 Medicare beneficiaries, totaling 7,695 services with total Medicare billing of $632,026. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Johnston, RI
- Active Since 07/28/2009
- Last Updated 05/25/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467683227
Products in Payments
- NURTEC ODT (Drug) $909.37
- ZENPEP (Drug) $887.26
- TRELEGY ELLIPTA (Drug) $374.15
- ELIQUIS (Drug) $354.80
- UBRELVY (Drug) $326.25
- Otezla (Drug) $325.81
- LINZESS (Drug) $305.99
- Creon (Drug) $286.92
- BREZTRI (Drug) $282.55
- SYMBICORT (Drug) $278.26
- Aimovig (Biological) $258.24
- SPIRIVA RESPIMAT (Drug) $256.02
- VOQUEZNA (Drug) $242.12
- Xofluza (Drug) $241.82
- CREON (Drug) $241.60
- XIFAXAN (Drug) $222.98
- NUZYRA (Drug) $193.07
- QULIPTA (Drug) $177.23
- AIRSUPRA (Drug) $164.50
- STIOLTO (Drug) $149.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Johnston
Jason Austin, D.o, D.O
Family Medicine — Payments: $15,321
Jordan Lizotte, R-Np, R-NP
Family Medicine — Payments: $719.54
W. Morgan, M.d, M.D
Family Medicine — Payments: $463.64
Dr. Joel Vander Meide, D.o, D.O
Family Medicine — Payments: $300.49
Dr. Alexandra Vander Meide, Md, MD
Family Medicine — Payments: $293.80
Scott Meyer, Md, MD
Family Medicine — Payments: $164.11